Elanco Animal Health INC Form 4 insider transactions

Elanco Animal Health's EVP, David S. Kinard, received significant equity compensation, including restricted stock units and stock options, increasing his beneficial ownership.

Elanco Animal Health's Executive Vice President, Ellen de Brabander, reported new equity grants and a disposition of shares for tax purposes.

Elanco Animal Health Inc.'s Executive Vice President, Timothy J. Bettington, reported significant equity grants and option awards, alongside a tax-related stock disposition, under a pre-arranged trading plan.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 56.6301 deferred stock units.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 110.8583 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, acquired 7.6217 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, acquired 7.5552 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 109.8905 deferred stock units, increasing his direct beneficial ownership.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 56.1357 deferred stock units.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 113.4934 deferred stock units, increasing his beneficial ownership to 18,959.0151 units.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 57.9762 deferred stock units, increasing his beneficial ownership to 7,538.3256 units.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, acquired 7.8029 deferred stock units as part of a pre-arranged plan.

Rajeev A. Modi, Elanco's EVP, acquired 60.2735 deferred stock units on January 9, 2026, increasing his direct beneficial ownership.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, acquired 8.1121 deferred stock units under a pre-arranged plan.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 117.9906 deferred stock units on January 9, 2026, increasing his beneficial ownership.

Elanco Animal Health Director Kapila K. Anand deferred cash retainer fees into 381.1312 Deferred Stock Units, increasing her beneficial ownership to 8,894.7414 units.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 122.5327 deferred stock units, increasing his beneficial ownership to 18,727.5311 units.

Elanco Animal Health Executive Vice President Rajeev A. Modi acquired 62.5938 deferred stock units on December 26, 2025.

Elanco Animal Health Inc. Director R. David Hoover reported a gift of 60,000 shares of common stock to a charitable trust, executed under a Rule 10b5-1 plan.

Elanco Animal Health Inc. Director Lawrence Kurzius purchased 10,000 shares of common stock at $21.30 per share.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, acquired 66.4453 deferred stock units at a price of $21.29 per unit.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 130.0723 deferred stock units, increasing his beneficial ownership in the company.

Elanco Animal Health Inc.'s Executive Vice President, Rajeev A. Modi, purchased 4,500 shares of common stock at $21.33 per share, increasing his direct beneficial ownership to 123,082 shares.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, purchased 6,950 shares of common stock for approximately $150,596 under a Rule 10b5-1 plan.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, purchased 22,000 shares of common stock for approximately $478,495 on December 11, 2025.

Elanco Animal Health Director Stacey Ma was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 119.0047 deferred stock units as part of an executive compensation plan.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 60.7916 deferred stock units at a price of $23.27 per unit.

Elanco Animal Health Inc. director Kapila K. Anand was granted 10,314 deferred stock units as part of an annual equity award.

Elanco Animal Health Director Denise Scots-Knight was granted 10,314 deferred stock units as an annual equity award.